cordycepin has been researched along with Kahler Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, LS; Gandhi, V; Stellrecht, CM | 1 |
1 other study(ies) available for cordycepin and Kahler Disease
Article | Year |
---|---|
RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Death; Cell Division; Chromatography, High Pressure Liquid; Deoxyadenine Nucleotides; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Activation; Humans; Multiple Myeloma; Neoplasm Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Receptors, Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Tumor Cells, Cultured | 2008 |